Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Bionoid Pharma (OTC PINK:BINP) has generated over $100,000 in revenue following a Binding Letter of Intent (LOI) with Your Supplement Supply Store The agreement marks the company's expansion into the health and wellness e-commerce sector.
Under the LOI terms, Bionoid retains all revenue generated during the transition period before finalizing the Asset Purchase Agreement (APA). The company's strategy involves acquiring e-commerce platforms and implementing its proprietary AI Maverick technology to enhance customer engagement and operational efficiency.
Bionoid Pharma (OTC PINK:BINP) ha generato oltre $100.000 di fatturato a seguito di una Lettera di Intenti (LOI) con Your Supplement Supply Store. L'accordo segna l'espansione dell'azienda nel settore e-commerce della salute e del benessere.
In base ai termini della LOI, Bionoid conserva tutto il fatturato generato durante il periodo di transizione prima di finalizzare l'Accordo di Acquisto di Asset (APA). La strategia dell'azienda prevede l'acquisizione di piattaforme e-commerce e l'implementazione della propria tecnologia proprietaria AI Maverick per migliorare il coinvolgimento dei clienti e l'efficienza operativa.
Bionoid Pharma (OTC PINK:BINP) ha generado más de $100,000 en ingresos tras una Carta de Intención (LOI) con Your Supplement Supply Store. El acuerdo marca la expansión de la compañía en el sector de comercio electrónico de salud y bienestar.
Bajo los términos de la LOI, Bionoid retiene todos los ingresos generados durante el periodo de transición antes de finalizar el Acuerdo de Compra de Activos (APA). La estrategia de la compañía implica adquirir plataformas de comercio electrónico e implementar su tecnología propietaria AI Maverick para mejorar el compromiso del cliente y la eficiencia operativa.
바이오노이드 제약(Bionoid Pharma) (OTC PINK:BINP)는 Your Supplement Supply Store와의 구속력 있는 의향서(LOI)에 따라 $100,000 이상의 수익을 창출했습니다. 이 계약은 회사의 건강 및 웰니스 전자상거래 부문으로의 확장을 나타냅니다.
LOI의 조건에 따라, 바이오노이드는 자산 구매 계약(APA)을 최종화하기 전 전환 기간 동안 생성된 모든 수익을 보유합니다. 회사의 전략에는 전자상거래 플랫폼을 인수하고 고객 참여와 운영 효율성을 높이기 위해 고유의 AI 매버릭 기술을 구현하는 것이 포함됩니다.
Bionoid Pharma (OTC PINK:BINP) a généré plus de 100 000 $ de revenus suite à une Lettre d'Intention (LOI) avec Your Supplement Supply Store. Cet accord marque l'expansion de l'entreprise dans le secteur du commerce électronique de la santé et du bien-être.
Selon les termes de la LOI, Bionoid conserve tous les revenus générés pendant la période de transition avant de finaliser l'Accord d'Achat d'Actifs (APA). La stratégie de l'entreprise consiste à acquérir des plateformes de commerce électronique et à mettre en œuvre sa technologie propriétaire AI Maverick pour améliorer l'engagement client et l'efficacité opérationnelle.
Bionoid Pharma (OTC PINK:BINP) hat über 100.000 $ Umsatz generiert, nachdem eine verbindliche Absichtserklärung (LOI) mit Your Supplement Supply Store unterzeichnet wurde. Das Abkommen markiert die Expansion des Unternehmens in den E-Commerce-Sektor für Gesundheit und Wellness.
Gemäß den Bedingungen der LOI behält Bionoid alle während der Übergangszeit vor der Finalisierung des Asset Purchase Agreements (APA) generierten Einnahmen. Die Strategie des Unternehmens besteht darin, E-Commerce-Plattformen zu akquirieren und seine proprietäre AI Maverick-Technologie einzusetzen, um das Kundenengagement und die operationale Effizienz zu verbessern.
- Generated over $100,000 in revenue from LOI agreement
- Secured immediate revenue retention during transition period
- Strategic expansion into health and wellness e-commerce sector
- None.
NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over
The LOI with Your Supplement Supply Store Ltd. represents a pivotal step in Bionoid's expansion into the health and wellness e-commerce sector. Under the terms of the agreement, Bionoid retains all revenue generated during the transition period prior to the finalization of the Asset Purchase Agreement (APA). This structure has enabled Bionoid to capture immediate value while ensuring a seamless integration process.
"The revenue generated from this agreement is a testament to the strength of our strategic partnerships and our ability to drive results even before completing the acquisition process," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "This success reinforces our commitment to building a robust e-commerce presence in the health and wellness sector and highlights the potential for future growth as we continue to execute our long-term vision."
Bionoid's strategy focuses on acquiring high-value e-commerce platforms and leveraging its proprietary AI Maverick technology to optimize customer engagement and operational efficiency. The success of this initial revenue generation further positions the company as a leader in the health and wellness market.
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a forward-thinking health and wellness company dedicated to expanding revenue streams and enhancing brand presence through strategic acquisitions and advanced AI technology. Its proprietary AI Maverick platform supports the company's mission to deliver innovative, AI-driven solutions that foster customer loyalty, operational excellence, and sustainable growth.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
X (formally Twitter)
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: bionoidpharma@gmail.com
SOURCE: Bionoid Pharma, Inc.
View the original press release on accesswire.com
FAQ
How much revenue did Bionoid Pharma (BINP) generate from the Your Supplement Supply Store LOI?
What is the purpose of Bionoid Pharma's (BINP) LOI with Your Supplement Supply Store?
How does Bionoid Pharma (BINP) plan to optimize its e-commerce operations?
What happens to the revenue generated during the LOI transition period for BINP?
